TRIFLUOPERAZINE vs TRILACICLIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TRIFLUOPERAZINE vs TRILACICLIB: Safety Overview
| Metric | TRIFLUOPERAZINE | TRILACICLIB |
|---|---|---|
| Total FAERS Reports | 369 | 226 |
| Deaths Reported | 2 | 29 |
| Death Rate | 0.5% | 12.8% |
| Hospitalizations | 252 | 96 |
| Average Patient Age | 44.5 yrs | 62.2 yrs |
| % Female Patients | 28.9% | 43.9% |
| FDA Approval Date | Approved Prior to Jan 1, 1982 | Feb 12, 2021 |
| Manufacturer | REMEDYREPACK INC. | Pharmacosmos Therapeutics Inc. |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Discontinued | Prescription |